Literature DB >> 20978768

Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer.

Seung Ho Kim1, Jae Young Lee, Jeong Min Lee, Joon Koo Han, Byung Ihn Choi.   

Abstract

OBJECTIVE: To determine whether change in the apparent diffusion coefficient (ADC) before and after neoadjuvant chemoradiation therapy (CRT) for locally advanced rectal cancer (LARC) would more accurately predict pathological complete response (pCR) than analysing the pre- or post-CRT ADC individually.
METHODS: 76 patients with LARC (≥ T3 or lymph node-positive) underwent pre- and post-CRT, 1.5-T diffusion-weighted imaging. A blinded radiologist measured the tumour ADCs. The three measures were compared with regard to CR and non-CR. To calculate accuracy for determining pCR, receiver-operating characteristic curve (ROC) analysis was applied to the three measures.
RESULTS: The post-CRT ADC (1.43 ± 0.10) (× 10(-3) mm(2)/s) and the percentage change (70.0 ± 23.5%) in the CR (n = 11) were significantly higher than those in the non-CR (n = 65) (1.14 ± 0.18, 30.2 ± 21.7%, respectively)(both, P < 0.0001). The pre-CRT ADC (0.85 ± 0.10) of the pCR did not differ significantly from that of the non-pCR (0.88 ± 0.14)(P = 0.4094). The post-CRT ADC showed comparable relative accuracy for determining pCR to that of the percentage change (P = 0.788). However, overall accuracy of the former (87%) was higher than that of the latter (75%) (P = 0.049).
CONCLUSION: Analyzing post-CRT ADC alone can reliably differentiate pCR from non-pCR in LARC.

Entities:  

Mesh:

Year:  2010        PMID: 20978768     DOI: 10.1007/s00330-010-1989-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  36 in total

1.  A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision.

Authors:  Julio García-Aguilar; Enrique Hernandez de Anda; Prayuth Sirivongs; Suk-Hwan Lee; Robert D Madoff; David A Rothenberger
Journal:  Dis Colon Rectum       Date:  2003-03       Impact factor: 4.585

2.  Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?

Authors:  R Hughes; R Glynne-Jones; J Grainger; P Richman; A Makris; M Harrison; R Ashford; R A Harrison; J I Livingstone; P J McDonald; J Meyrick Thomas; I C Mitchell; J M A Northover; R Phillips; M Wallace; A Windsor; J R Novell
Journal:  Int J Colorectal Dis       Date:  2005-04-30       Impact factor: 2.571

3.  Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?

Authors:  T Denecke; B Rau; K-T Hoffmann; B Hildebrandt; J Ruf; M Gutberlet; M Hünerbein; R Felix; P Wust; H Amthauer
Journal:  Eur Radiol       Date:  2005-04-02       Impact factor: 5.315

4.  Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.

Authors:  Ying-Shi Sun; Xiao-Peng Zhang; Lei Tang; Jia-Fu Ji; Jin Gu; Yong Cai; Xiao-Yan Zhang
Journal:  Radiology       Date:  2009-12-17       Impact factor: 11.105

5.  Sonography transmission gel as endorectal contrast agent for tumor visualization in rectal cancer.

Authors:  Seung Ho Kim; Jeong Min Lee; Min Woo Lee; Gi Hyeon Kim; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2008-07       Impact factor: 3.959

Review 6.  Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer.

Authors:  Thomas Borschitz; Daniel Wachtlin; Markus Möhler; Heinz Schmidberger; Theodor Junginger
Journal:  Ann Surg Oncol       Date:  2007-12-28       Impact factor: 5.344

7.  Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Authors:  Seung Ho Kim; Jeong Min Lee; Hee Sun Park; Hyo Won Eun; Joon Koo Han; Byung Ihn Choi
Journal:  J Magn Reson Imaging       Date:  2009-05       Impact factor: 4.813

Review 8.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

Review 9.  Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.

Authors:  Daniel M Patterson; Anwar R Padhani; David J Collins
Journal:  Nat Clin Pract Oncol       Date:  2008-02-26

10.  Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy.

Authors:  Brunella Barbaro; Cecilia Fiorucci; Carmen Tebala; Vincenzo Valentini; Maria Antonietta Gambacorta; Fabio Maria Vecchio; Gianluca Rizzo; Claudio Coco; Antonio Crucitti; Carlo Ratto; Lorenzo Bonomo
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

View more
  51 in total

1.  T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer.

Authors:  Ewelina Kluza; Esther D Rozeboom; Monique Maas; Milou Martens; Doenja M J Lambregts; Jos Slenter; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2012-07-10       Impact factor: 5.315

2.  Diffusion-weighted magnetic resonance imaging for prediction of tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer.

Authors:  Hiroshi Doi; Naohito Beppu; Takashi Kato; Masashi Noda; Hidenori Yanagi; Naohiro Tomita; Norihiko Kamikonya; Shozo Hirota
Journal:  Mol Clin Oncol       Date:  2015-07-21

3.  Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.

Authors:  Gang Cai; Ye Xu; Ji Zhu; Wei-Lie Gu; Shuai Zhang; Xue-Jun Ma; San-Jun Cai; Zhen Zhang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

4.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

Authors:  Stephanie Nougaret; Hebert Alberto Vargas; Yulia Lakhman; Romain Sudre; Richard K G Do; Frederic Bibeau; David Azria; Eric Assenat; Nicolas Molinari; Marie-Ange Pierredon; Philippe Rouanet; Boris Guiu
Journal:  Radiology       Date:  2016-02-26       Impact factor: 11.105

5.  The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Authors:  Jing Yu; Qing Xu; Jia-Cheng Song; Yan Li; Xin Dai; Dong-Ya Huang; Ling Zhang; Yang Li; Hai-Bin Shi
Journal:  Eur Radiol       Date:  2016-09-08       Impact factor: 5.315

Review 6.  Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

Authors:  Alicia S Borggreve; Lucas Goense; Hylke J F Brenkman; Stella Mook; Gert J Meijer; Frank J Wessels; Marcel Verheij; Edwin P M Jansen; Richard van Hillegersberg; Peter S N van Rossum; Jelle P Ruurda
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

Review 7.  Diffusion-weighted imaging in rectal cancer: current applications and future perspectives.

Authors:  Niels W Schurink; Doenja M J Lambregts; Regina G H Beets-Tan
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

8.  Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer?

Authors:  Lian-Ming Wu; Jiong Zhu; Jiani Hu; Yan Yin; Hai-Yan Gu; Jia Hua; Jie Chen; Jian-Rong Xu
Journal:  Int J Colorectal Dis       Date:  2013-03-21       Impact factor: 2.571

Review 9.  Advances and challenges in treatment of locally advanced rectal cancer.

Authors:  J Joshua Smith; Julio Garcia-Aguilar
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

10.  Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology.

Authors:  Francesco De Cobelli; Francesco Giganti; Elena Orsenigo; Michaela Cellina; Antonio Esposito; Giulia Agostini; Luca Albarello; Elena Mazza; Alessandro Ambrosi; Carlo Socci; Carlo Staudacher; Alessandro Del Maschio
Journal:  Eur Radiol       Date:  2013-04-16       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.